BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 38385734)

  • 21. Breast cancer risk association with postmenopausal hormone therapy: Health Insurance Database in South Korea-based cohort study.
    Yuk JS; Kim T; Cho H; Gwak G
    Eur J Endocrinol; 2024 Jan; 190(1):1-11. PubMed ID: 38128117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eligibility criteria for using menopausal hormone therapy in breast cancer survivors: a safety report based on a systematic review and meta-analysis.
    Coronado PJ; Gómez A; Iglesias E; Fasero M; Baquedano L; Sánchez S; Ramírez-Polo I; de la Viuda E; Otero B; Llaneza P; Mendoza N; Lubián DM;
    Menopause; 2024 Mar; 31(3):234-242. PubMed ID: 38385734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Menopausal Hormone Therapy and Mortality: A Systematic Review and Meta-Analysis.
    Benkhadra K; Mohammed K; Al Nofal A; Carranza Leon BG; Alahdab F; Faubion S; Montori VM; Abu Dabrh AM; Zúñiga Hernández JA; Prokop LJ; Murad MH
    J Clin Endocrinol Metab; 2015 Nov; 100(11):4021-8. PubMed ID: 26544652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Menopausal hormone therapy and women's health: An umbrella review.
    Zhang GQ; Chen JL; Luo Y; Mathur MB; Anagnostis P; Nurmatov U; Talibov M; Zhang J; Hawrylowicz CM; Lumsden MA; Critchley H; Sheikh A; Lundbäck B; Lässer C; Kankaanranta H; Lee SH; Nwaru BI
    PLoS Med; 2021 Aug; 18(8):e1003731. PubMed ID: 34339416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Menopausal hormone therapy: a systematic review of cost-effectiveness evaluations.
    Velentzis LS; Salagame U; Canfell K
    BMC Health Serv Res; 2017 May; 17(1):326. PubMed ID: 28476121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short-term and long-term effects of tibolone in postmenopausal women.
    Formoso G; Perrone E; Maltoni S; Balduzzi S; Wilkinson J; Basevi V; Marata AM; Magrini N; D'Amico R; Bassi C; Maestri E
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD008536. PubMed ID: 27733017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety of systemic hormone replacement therapy in breast cancer survivors: a systematic review and meta-analysis.
    Poggio F; Del Mastro L; Bruzzone M; Ceppi M; Razeti MG; Fregatti P; Ruelle T; Pronzato P; Massarotti C; Franzoi MA; Lambertini M; Tagliamento M
    Breast Cancer Res Treat; 2022 Jan; 191(2):269-275. PubMed ID: 34731351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The management of menopause in women with a history of endometriosis: a systematic review.
    Gemmell LC; Webster KE; Kirtley S; Vincent K; Zondervan KT; Becker CM
    Hum Reprod Update; 2017 Jul; 23(4):481-500. PubMed ID: 28498913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interventions for promoting habitual exercise in people living with and beyond cancer.
    Turner RR; Steed L; Quirk H; Greasley RU; Saxton JM; Taylor SJ; Rosario DJ; Thaha MA; Bourke L
    Cochrane Database Syst Rev; 2018 Sep; 9(9):CD010192. PubMed ID: 30229557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short and long term effects of tibolone in postmenopausal women.
    Formoso G; Perrone E; Maltoni S; Balduzzi S; D'Amico R; Bassi C; Basevi V; Marata AM; Magrini N; Maestri E
    Cochrane Database Syst Rev; 2012 Feb; (2):CD008536. PubMed ID: 22336846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormone therapy for preventing cardiovascular disease in post-menopausal women.
    Boardman HM; Hartley L; Eisinga A; Main C; Roqué i Figuls M; Bonfill Cosp X; Gabriel Sanchez R; Knight B
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD002229. PubMed ID: 25754617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of menopausal hormone therapy on the risk of melanoma and keratinocyte skin cancer: A systematic review and meta-analysis of observational studies.
    Lallas K; Anagnostis P; Theocharis P; Boureka E; Kyrgidis A; Klonos E; Papazisis G; Apalla Z; Lallas A; Vakirlis E
    Maturitas; 2023 Feb; 168():20-28. PubMed ID: 36372010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Associations between Menopausal Hormone Therapy and Colorectal, Lung, or Melanoma Cancer Recurrence and Mortality: A Narrative Review.
    Fiol G; Lete I; Nieto L; Santaballa A; Pla MJ; Baquedano L; Calaf J; Coronado P; de la Viuda E; Llaneza P; Otero B; Sánchez-Méndez S; Ramírez I; Mendoza N;
    J Clin Med; 2023 Aug; 12(16):. PubMed ID: 37629305
    [No Abstract]   [Full Text] [Related]  

  • 34. Dehydroepiandrosterone for women in the peri- or postmenopausal phase.
    Scheffers CS; Armstrong S; Cantineau AE; Farquhar C; Jordan V
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD011066. PubMed ID: 25879093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A systematic review of randomised clinical trials - The safety of vaginal hormones and selective estrogen receptor modulators for the treatment of genitourinary menopausal symptoms in breast cancer survivors.
    Hussain I; Talaulikar VS
    Post Reprod Health; 2023 Dec; 29(4):222-231. PubMed ID: 37840298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hormone replacement therapy for women previously treated for endometrial cancer.
    Edey KA; Rundle S; Hickey M
    Cochrane Database Syst Rev; 2018 May; 5(5):CD008830. PubMed ID: 29763969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of postmenopausal women: Collège National des Gynécologues et Obstétriciens Français (CNGOF) and Groupe d'Etude sur la Ménopause et le Vieillissement (GEMVi) Clinical Practice Guidelines.
    Trémollieres FA; Chabbert-Buffet N; Plu-Bureau G; Rousset-Jablonski C; Lecerf JM; Duclos M; Pouilles JM; Gosset A; Boutet G; Hocke C; Maris E; Hugon-Rodin J; Maitrot-Mantelet L; Robin G; André G; Hamdaoui N; Mathelin C; Lopes P; Graesslin O; Fritel X
    Maturitas; 2022 Sep; 163():62-81. PubMed ID: 35717745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The oncologic impact of hormone replacement therapy in premenopausal breast cancer survivors: A systematic review.
    Wang Y; Lewin N; Qaoud Y; Rajaee AN; Scheer AS
    Breast; 2018 Aug; 40():123-130. PubMed ID: 29763858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hormone therapy for sexual function in perimenopausal and postmenopausal women.
    Lara LA; Cartagena-Ramos D; Figueiredo JB; Rosa-E-Silva ACJ; Ferriani RA; Martins WP; Fuentealba-Torres M
    Cochrane Database Syst Rev; 2023 Aug; 8(8):CD009672. PubMed ID: 37619252
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.